SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hypertension Diagnostics Inc (HDII)
HDII 0.00010000.0%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scott_jiminez who wrote (91)2/14/2002 10:43:11 PM
From: scott_jiminez  Read Replies (1) of 120
 
A quarter-to-quarter near-tripling of revenues from the Profilor.

biz.yahoo.com

And this during a period when the company says business conditions were difficult.

83 profilor placements now in 23 states and 12 'organizations' representing the device. Calculations show that ~150 placements (@ 3 uses/day) would be the breakeven level for the company.

This placement level should be easily attainable in the near future (and that usage rate is a low-ball estimate).

In short, the company may be reaching a cash-flow break-even position earlier than their conservative estimates portray.

This earnings report provides the rationale for the 60+% drop in short interest in the stock over the past couple of months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext